Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: UroGen Pharma Ltd., 3 years.
UroGen Pharma Ltd.
Director
Keros Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2022 | UroGen Pharma Ltd. | Option exercise | +2,211 | $5.00 | $11,055 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.